Neil Herskowitz - 29 Jul 2022 Form 4 Insider Report for MUSTANG BIO, INC. (MBIO)

Reporting relationship: Director
Issuer ticker: MBIO
Reported as of: 29 Jul 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2023, 16:50:19 UTC
Prior SEC filing: 25 Jul 2022
Next SEC filing: 15 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Matthew Wein, Attorney-in-Fact

Key filing fact

Neil Herskowitz filed Form 4 for MUSTANG BIO, INC. (MBIO) on 03 Apr 2023.

Key facts

This page summarizes Neil Herskowitz's Form 4 filing for MUSTANG BIO, INC. (MBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Apr 2023, 16:50.

Change

Previous filing in this sequence was filed on 25 Jul 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MBIO transaction

COMMON STOCK, PAR VALUE $0.0001

Award

Transaction value: $0
Shares: +71,664
Change %: +62%
Price: $0.000000
Shares after: 186,861
Date: 29 Jul 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date.

Footnote F2

Includes restricted share units, which vest over various time periods.